You are here

Coronary Intervention & Surgery


Hospitals ranked in the top 50 for cardiology and heart surgery by U.S. News and World Report appear no better at performing PCI than unranked hospitals, according to an analysis of more than 500,000 procedures performed at 654 hospitals.

PCI of chronic total occlusions (CTOs) can be safely performed by expert operators and provides significant benefit to patients with reduced left ventricular ejection fraction (LVEF) or diabetes, according to a series of studies published Nov. 13 in JACC: Cardiovascular Interventions.

Scaffold discontinuity, malapposition and neoatherosclerosis were found to be the leading mechanisms behind very late scaffold thrombosis (VLScT) in cardiac patients implanted with bioresorbable devices, investigators from the INVEST registry have reported.

Recent studies have shown robotic PCI to be a feasible way to treat coronary artery disease. But at the annual Transcatheter Cardiovascular Therapeutics (TCT) conference Oct. 30, Ryan D. Madder, MD, took the conversation a step further: Will it eventually be possible to perform “tele-stenting” over long distances?

Research presented Nov. 2 at the Transcatheter Cardiovascular Therapeutics scientific symposium in Denver demonstrates patients with stable coronary artery disease (CAD) and abnormal fractional flow reserve (FFR) derive better clinical outcomes with PCI at similar cost to medical therapy alone.


Recent Headlines

ACC.17: Patients with CTOs have similar outcomes with PCIs, optimal medical treatment

Patients with chronic total occlusions (CTOs) had similar results whether they underwent PCIs or received optimal medical treatment, according to a prospective, open-label, randomized trial.

FDA warns of increased major adverse cardiac events with the Absorb dissolving stent

After reviewing data from a clinical trial, the FDA issued a letter to healthcare providers informing them that patients who received the Absorb bioresorbable vascular scaffold had an increased rate of major adverse cardiac events compared with patients treated with the Xience drug-eluting stent.

Ischemia, bleeding increase mortality risk in patients a year after coronary stenting

Patients who had ischemic and bleeding events 12 to 33 months after undergoing coronary stenting had an increased mortality risk, according to a post hoc analysis of a randomized study.

CMS approves two more facilities to perform carotid artery stenting for high risk patients

Since the beginning of the year, CMS has approved two facilities for performing carotid artery stenting for high risk patients.

Study examines treatments for atrial fibrillation patients following PCI with stenting

Daiichi Sankyo Company announced on March 6 that the first patient had enrolled in a Phase 3b study evaluating edoxaban (Savaysa) versus a vitamin K antagonist in patients with atrial fibrillation following PCI with stenting.

Rates of inappropriate, elective PCIs decline in New York

Between 2010 and 2014, the rate of inappropriate PCIs and the use of PCI for elective procedures in New York decreased significantly, according to a database analysis. 

FDA approves stent to treat coronary bifurcation lesions involving large side branches

The FDA approved the Tryton Side Branch Stent on March 6 to treat coronary bifurcation lesions involving large side branches that are appropriate for a 2.5 mm or larger stent.

FDA approves coronary stent system for patients with ischemic heart disease

The FDA approved the COBRA PzF NanoCoated coronary stent system to improve coronary luminal diameter in certain patients with ischemic heart disease.

Hospitals, patients may benefit from transradial PCIs, same-day discharges

A recent study suggests that hospitals could save $332 million annually simply by switching to a transradial approach to PCIs and discharging patients on the same day as they are admitted.

New 'no-touch' CABG procedure reduces chance of stroke by 78%

A new study by researchers at the University of Sydney in Australia found that a new heart bypass surgical technique that requires no manipulation of heart vessels could reduce the chance of stroke by 78 percent.